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Abstract
Background: The serine/threonine mammalian Ste-20 like kinases (MSTs) are key regulators of apoptosis, cellular
proliferation as well as polarization. Deregulation of MSTs has been associated with disease progression in prostate and
colorectal cancer. The four human MSTs are regulated differently by C-terminal regions flanking the catalytic domains.
Principal Findings: We have determined the crystal structure of kinase domain of MST4 in complex with an ATP-mimetic
inhibitor. This is the first structure of an inactive conformation of a member of the MST kinase family. Comparison with
active structures of MST3 and MST1 revealed a dimeric association of MST4 suggesting an activation loop exchanged
mechanism of MST4 auto-activation. Together with a homology model of MST2 we provide a comparative analysis of the
kinase domains for all four members of the human MST family.
Significance: The comparative analysis identified new structural features in the MST ATP binding pocket and has also
defined the mechanism for autophosphorylation. Both structural features may be further explored for inhibitors design.
Enhanced version: This article can also be viewed as an enhanced version (http://plosone.org/enhanced/pone.0011905/)
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plugin are available in Text S1.
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Introduction
The Sterile-20 protein kinase (Ste20) was first identified in yeast as a
key molecule involved in pheromone signaling [1] and has since been
found to be involved in the regulation of a large number of diverse
cellular functions including cell polarization [2,3], actin organization
[4,5], regulation of exit from mitosis [6] and apoptosis [7,8].
Subsequently several mammalian Ste20-like (MST) kinases
sharing homology with the yeast ste20 were identified and grouped
into two structurally distinct families: p21-activated kinase (PAK)
and the germinal centre kinase (GCK) [9]. The GCK group can
be further subdivided into GCKI to GCKVIII [10,11,12,13] and
are characterized by the positioning of the kinase domain at the N-
terminus, as opposed to the PAK group where the kinase domain
can be found at the C-terminus. GCKs are also devoid of an N-
terminal GTP-binding domain, found in the PAKs.
The subfamily GCKII includes MST1 and MST2, two upstream
kinases implicated in cell growth and apoptosis. Both kinases can be
activated via caspase-mediated cleavage of the C-terminal inhibi-
tory domain [14]. Activation of MST1 induces activation of JNK
and p38 during apoptosis events in certain cell types [15,16,17].
Additionally, MST1 can also induce apoptosis via phosphorylation
of histone 2B [7,18], promotion of chromatin condensation [19,20]
and FOXO3 nuclear translocation in neuronal cells [21]. It has
been further found that MST1 acts as an essential mediator in
apoptosisofK-ras transformed cells[22,23] and that theDrosophila
homologue Hippo phosphorylates the tumor suppressor protein
Salvador and is involved in the regulation of expression of cyclin E
and apoptosis inhibitor DIAP1 [24]. Similarly, the human
orthologue of Salvador (hSav) can bind and be phosphorylated by
both MST1 and 2 [25]. Additionally, MST2 is involved in the
LATS tumor suppressor pathway via complexation with hSav,
RASSF1A, Nore1 and LATS1, resulting in the phosphorylation of
LATS1 and transcription of proapoptotic genes [26,27,28].
The subfamily GCKIII contains MST3 and MST4 which share
almost 90% amino acid identity in the kinase domain but less than
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e11905Figure 1. Alignment of human MST kinase domains. The secondary elements shown in the alignment were derived from the structure of MST4
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subfamily II (MST1 and MST2), members of these two groups have
apparently different cellular functions. Neither MST3 nor MST4
are capable of activating JNK and p38 MAPK kinase activity
[29,30] and both were shown to activate ERK in different cell lines,
albeit via different pathways [29,31,32]. In contrast to MST1 and
MST2 the C-terminus of MST3 and MST4 stimulates kinase
activity bypromoting auto-phosphorylation. MST4 hasbeen shown
to phosphorylate the actin remodeler Ezrin at its regulatory residue
T567 resulting in transmission of cell polarization signals [33].
All MSTs (1–4) are expressed almost ubiquitously in all tissues,
with higher expression levels found in placenta (MST1, MST2 and
MST4), skeletal tissues (MST1, MST2, MST3), kidney (MST1 and
MST2), heart (MST3), pancreas (MST3), thymus, and peripheral
blood leukocytes (MST4) [29,30,34,35,36,37]. Decreasing levels of
MST2 has been observed to correlate with loss of RASSF2 in
human colorectal carcinomas [38]. Additionally, MST1 and MST4
have been implicated in prostate cancer, whereby MST1 protein
levels declined with disease progression [39] and MST4 expression
has been correlated with tumourigenicity of human prostate cancer
cell lines [36]. Overexpression of MST4 induces anchorage-
independent growth and increases in vitro proliferation as well as in
vivotumourigenesisinprostatecancercelllines[40] suggestingarole
in prostate cancer progression. MST4 may also be involved in
regulation of cell migration via its interaction with the Golgi protein
GM130. Binding to GM130 activates MST4 as well as YSK, a
related kinase, by promoting autophosphorylation of a conserved
threonine within the activation segment. Interference with the
kinase function perturbs perinuclear Golgi organization, cell
migration, and invasion into type I collagen [41].
Other physiological functions of the MSTs include their possible
involvement in the immune system. MST1 is implicated in cardiac
apoptosis events (e.g. cardiac dilation, apoptosis and fibrosis after
myocardial infarction [42]). MST1 has also been suggested to
regulate lymphocyte polarity and adhesion, somatic hypermuta-
tion, class switching in B cells and apoptosis of eosinophils (see [9]
for review). MST3 has been described to use metal ions other than
Mg




2+. Interestingly a variant of MST3 is expressed uniquely in
brain, where Mn
2+ and Zn
2+ are abundant [32,43].
Here we present the crystal structure of the unphosphorylated
kinase domain of human MST4 refined at 2.35 A ˚ resolution in
complex with an ATP mimetic quinazoline inhibitor. We compare
the crystal structures of all available MST kinase domains (MST1,
3 and 4) and a homology model (MST2) to derive information
integrating structure and function.
Results and Discussion
Overall structures: kinase domain
The overall structure of the kinase domains of MST1, MST3 and
MST4 areverysimilar, as expected for their high degree ofsequence
conservation, epitomized by 90% identity between the kinase
domains of MST3 and MST4 (Figure 1). Nevertheless, structural
differencesresultedfromdifferential phosphorylationstates,complex
with ligands and crystal forms provide information on the structural
plasticity and regulation of this group of kinases (Figure 2).
The structures of MST1 and MST3 used for comparison with
our experimental structure of MST4 are available in the protein
data base whereas additional structures of MST3 have been
reported recently [44].
The crystal structure of MST1 (PDB ID: 3COM) has been
determined without bound cofactor (apo structure) whereas MST3
(PDB ID: 3CKX) has been co-crystallised with a non-selective
Figure 2. Overall structure of the MST kinase domains. Superimposition of the C-lobe from the three MST structures: Active apo MST1
(magenta, PDB ID: 3COM); Active MST3 (green, PDB ID: 3A7J) in complex with ADP (sticks) and Mn
2+ ions (spheres); Inactive MST4 (blue, PDB ID:
3GGF) in complex with a quinazoline inhibitor (sticks) and Cd
2+ (sphere). Phosphorylated threonine residues (Tpo) are shown as sticks.
doi:10.1371/journal.pone.0011905.g002
Human MST Kinases
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an active conformation, with well-defined activation loops (A-loops)
and the canonical salt-bridge between Lys59 and Glu73 (MST1
numbering),despitethedifferenceinthenumberof phosphorylated
sites. The A-loop of MST1 is diphosphorylated (Thr177, Thr183 -
UniProt numbering for Q13043) while that of MST3 is monopho-
sphorylated in the canonical position (Thr190- UniProt numbering
for Q9Y6E0-1; numbered as Thr163 in the structure PDB ID:
3CKX). The crystal structure of MST4 (PDB ID: 3GGF; data
collection and refinement statistics in table 1) has been solved in
complex with an ATP mimetic quinazoline inhibitor. Interestingly,
this structure has captured MST4 in its inactive form with a
partially disordered, unphosphorylated A-loop. Finally, the con-
formations adopted by the aC-helix from MST4 also differ from
those seen in the structures of the other two MSTs.
The ATP binding site
Regardless of the presence of ligands, the structure of the ATP
binding site is very similar for all three MST kinases (Figure 3A–
D). In MST3 the bulk of the staurosporine ligand mimics the
structure of the ATP adenine rings and sits in the flat cleft between
the two lobes. As with MST1, hydrophobic regions above and
below the ligand clamp it in place. A minor modification of the
immediate pocket is seen in MST3: Ile15 replaces Leu36 in
MST1. At the hinge backbone, hydrogen-bonding was observed
between two main-chain functional groups; the amide of Leu87
and carbonyl of Glu85, and the staurosporine molecule.
The glycine-rich loop was well ordered in MST3 structures as
expected in kinases with a bound ligand. However, residues of the
glycine-rich loop have high B-factors in comparison with the rest
of the molecule: both structures (in complex with staurosporine in
3CKX and ADP in 3A7J) are lacking the additional stabilization
of the glycine-rich loop attributed to the gamma phosphate of the
ATP. This can be illustrated by a comparison with the structure of
related ser/thr kinase TAO2 which has been co-crystallised with
ATP (PDB ID: 1U5R)(Figure 3F).
The binding of the quinazoline inhibitor in MST4 exhibits some
interesting features not present in the MST1 or MST3 structures
(Figure 3D–F). The presence of a pyrazole group in the ligand
introduces the possibility of another H-bond with the hinge region.
In addition to the two hydrogen bonds observed in the structure of
MST3 in complex with staurosporine, the glutamic acid carbonyl
(Glu100) is involved in a third hydrogen bond to the pyrazole group
of the quinazoline inhibitor in MST4 (Figure 3D). Additionally
electron density data has identified the positions of seven cadmium
ions in the asymmetric unit in the crystal structure of MST4, two of
which participates in the binding of the ligand in each monomer
(Figure 3D). A four-coordinate Cd
2+ ion (distorted tetrahedral
geometry) sits in a location towards the open face of the ligand
pocket, close to site occupied by ATP ribose 29 and 39 oxygen atoms.
It is coordinated by two water molecules, the carboxy group of
Asp109, and by a nitrogen atom of the adenine ring. Interestingly,
despite the partially disordered A-loop, the geometry of the MST4
ATP pocket has undergone only limited change when compared to
MST1 and 3 in the region occupied by the quinazoline ligand.
Superposition of the MSTs with the TAO2 kinase in complex
with ATP suggests that the ribose group of ATP does not form any
direct interaction with any of the residues lining the ATP binding
pocket (Figure 3F). This is further contrasted when other kinases
(e.g. PAK kinases) are superimposed – where conserved residues
(PAK6 Asp530; PDB ID: 2C30) can interact directly with the
oxygen atoms from the ribose group, enforcing the correct
geometry for catalysis. Alternatively, an absolutely conserved Asp
residue in MSTs (Asp109 in MST4) is found in a position allowing
indirect interaction to the ATP ribose. This interaction could be
mediated through a water molecule as seen in the structure of
MST3 (PDB ID: 3A7J) or a cadmium ion as seen in MST4 (PDB
ID: 3GFF). Additionally, in the STE kinase TAO2 (PDB ID:
1U5R) the aspartate residue coordinates a lysine, which in turn
interacted with the ribose group. This observation indicates that
the positioning of the ribose group through its oxygen atoms by the
conserved aspartate requires the presence of a bridging element,
which could be charged – a feature that could be explored for
future inhibitor design.
We have also performed screening of MST4 against a panel of
1457 inhibitors, using thermal stability shift assay (Figure 4).
Several compounds have been identified as strong binders,
however most are non-specific kinase inhibitors that were
previously described in the literature. This is also the case of the
quinazoline inhibitor in the structure of MST4. The screening
experiments were performed without adding cadmium to the
buffer. The observed strong interactions between inhibitors and
MST4 suggest that the bridging between Asp109 and ligand could
be performed by other molecules, such as water, as observed in the
structure of MST3 in complex with ADP (PDB ID: 3A7J).
a-helix C in MST4 shows an alternative conformation
The position of the aC-helix in MST1 and 3 is typical for an
active conformer of a kinase. Lys59 and Glu73 (MST1) are
orientated towards each other with geometry indicative of salt-
bridge formation between the residues, with the aC-helix, well-
positioned against the N-terminal lobe (N-lobe). The confor-
mation of active MST structures( M S T 1a n dM S T 3 )i ss i m i l a r
Table 1. Data Collection and Refinement Statistics.
Complex MST4-quinazoline
PDB accession code 3ggf
Wavelength (A ˚) 0.8800
Spacegroup P212121
Unit cell dimensions a=65.92, b=91.25, c=108.97 A ˚
a=b=c=90.0u
Resolution range






















b (A ˚2) 21.8/24.5/32.2




aValues in brackets show the statistics for the highest resolution shell.
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in PAKs, which also belong to the STE family. It should be
mentioned that the helix aA is present in the structures of
PAKs and TAO2, stabilizing aC in an active conformation.
Thus, the lack of the aA helix in the structures of active MST1
and MST3 does not seem to impact on the aCc o n f o r m a t i o n
(Figure 5).
Surprisingly, in the inactive structure of MST4 the aC helix is
adopting a ‘swung-up’ conformation, bringing the N-terminal
region of the aC helix closer to the N-terminus of the kinase
domain. The approximately 13 degrees swinging motion (when
compared to the same helix in MST3) allows the A-loop to also
swing towards the N-lobe, resulting in the conformation captured
in the crystal of MST4.
Dimerization through activation loop exchange as a
model for MST autophosphorylation
The A-loop in both MST1 and MST3 are well-defined and in
an active conformation. Interestingly it is diphosphorylated at both
Thr177 and Thr183 in MST1 while MST3 is phosphorylated only
at Thr178 (structure numbering, PDB ID: 3A7J). Structural
superimposition shows that the canonical position (MST1:
Thr177, MST3: Thr178) is well conserved, and so are the
conformation adopted by the structures of MST1 and MST3 (Ca
RMSD: 0.4 A ˚). In these structures, the canonical phosphorylated
sites are coordinated by two conserved arginine residues (MST1:
Arg148, Arg181; MST3: Arg143, Arg176).
In MST4, the unphosphorylated A-loop is positioned in a vastly
different orientation when compared to MST1 and MST3
(Figure 2). It is poorly defined, where the visible portions
belonging to the N-terminal section of the A-loop are seen
adopting a conformation reaching towards the N-lobe, relative to
the active form. The C-terminal section is seen extending away
from the main core of the kinase domain and reaching into a
neighboring kinase molecule, thus correlated with the dimerization
seen in this crystal form (Figure 6A).
In the crystal of MST1, the kinase molecules are positioned
roughly perpendicular to each other. In such orientation, the
active site is out of reach to phosphorylate the A-loop residues
Thr177 and Thr183. Similarly, in the structure of MST3, none of
the symmetry-related neighbors are found to position the observed
phosphorylation site close to the active site, suggesting that the
crystal packing of neither MST1 nor MST3 reflect the kinase-
kinase interaction positioning necessary for autophosphorylation.
Conversely, as described above, the asymmetric unit of MST4
contains a symmetry-related dimer where the visible C-terminal
section of the A-loop of the molecules is contacting each other.
Four residues (178-TFVGT-182) of the molecule A are packing
against the same residues in molecule B in an anti-parallel
disposition, forming a series of hydrogen bonds: each Thr178
main chain carbonyl interacts with Thr182-OG1 from the other
molecule; likewise each Val180 main chain nitrogen hydrogen
bonds to Gly181 main chain carbonyl from the neighboring
molecule. Additionally, the side chains of Val180 are involved in
hydrophobic contacts. More critically, the canonical Thr178 to be
phosphorylated is found in close proximity to the phosphate
transfer site of the neighboring molecule in the dimer (Figure 6C).
The combined observation of the dimer in the asymmetric unit
and the A-loop conformation suggest that the kinase domain of
Figure 3. ATP binding site. Different kinases are color coded as follows: MST1: magenta; MST3: green; MST4: blue. Binding site surfaces are
represented by semi-transparent orange skins. A. MST1 apo (PDB ID: 3COM); B. MST3 in complex with staurosporine (PDB ID: 3CKX); C. MST3 in
complex with ADP (PDB ID: 3A7J); D. MST4 in complex with a quinazoline inhibitor (PDB ID: 3GGF); E. Fo-Fc difference map of the quinazoline
inhibitor bound to MST4 (PDB ID: 3GGF). Isosurface contouring levels: 1s (blue) and 3s (red). This view is rotated 90u on the X-axis (as compared to
the orientation shown in (D) and looks towards the C-lobe; F. Details of the active site of MST4 in complex with a quinazoline inhibitor (blue),
superimposed to PAK6 (yellow; PDB ID: 2C30) and TAO2 in complex with ATP (grey; PDB ID: 1U5R).
doi:10.1371/journal.pone.0011905.g003
Human MST Kinases
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doi:10.1371/journal.pone.0011905.g004
Human MST Kinases
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the inactive and partially disordered A-loop can reach satisfactorily
into the substrate binding site of the other kinase in the dimer. In
this process Thr178 can be positioned at the catalytic site to be
phosphorylated. Similar autophosphorylation mechanism where
the A-loops are exchanged in a ‘face-to-face’ kinase dimer has
been described before for SLK, LOK and DAPK3 [45,46].
The observed reciprocal interaction of A-loops in the MST4
dimer implies the availability of a site binding the swapped A-
loops. The observed A-loop exchange also creates a distinction
between the sequence requirement for the autophosphorylation
mechanism and the physiological consensus sequence. Albeit the
autophosphorylation consensus has been defined in all human
MSTs as KRNT*(V/F)(I/V)GTPFWMAPEVI [9], the physio-
logical consensus has not been determined so far. Ultimately, A-
loop swapping allows a single kinase molecule to catalyze two
different subsets of residues, which can be explored by designing of
peptides (or peptidomimetics) targeting at either the autopho-
sphorylation or physiological consensus binding sites.
While the structure of MST4 supports the A-loop exchange
autophosphorylation model, it probably represents an intermedi-
ate, pre-catalytic state. The catalysis is dependent on the correct
positioning of the aC helix and establishment of the activation salt-
bridge, which are not present in the present structure of MST4.
It is important to emphasize that while autophosphorylation of
MSTs seems to involve dimerization, it does not necessarily imply
that this is the physiological dimer for the full-length protein.
Previous reports have identified a C-terminal dimerization domain
in MST1 and MST2, which is not required for kinase activity [47].
Additionally, MST2 lacking the dimerization domain can still
autophosphorylate [48]. This suggests that although dimerization
driven by the C-terminal domain (at least in MST1 and MST2)
might be necessary for other biological/regulatory functions,
autophosphorylation in trans will probably involve the face-to-face
disposition seen in the asymmetric unit of MST4 crystals. We were
interested to see if MST4 indeed dimerizes in solution. To this end
we performed analytical ultracentrifugation sedimentation velocity
experiments. Analysis of the sedimentation data collected on the
unphosphorylated protein indicated clearly the presence of MST4
dimers in solution (Figure 7A). In addition, recombinant MST4
are autophosphorylated in solution at three sites, as shown by
electrospray mass spectroscopy (Figure 7B).
C-terminal a-helix K
At the C-terminus of the full-length MSTs, we find a regulatory
domain, which has been described to be involved in dimerization
and not essential to the kinase activity [47]. It can be removed via
cleavage with caspase - however the reported cleavage site is
located around 30 residues from the last observable residue in the
crystal structures [15,49]. The regulatory domain is connected to
the kinase domain via an a-helix (aK) which interacts with the C-
terminal lobe (C-lobe) with a multitude of aromatic and
hydrophobic interactions. The aK helix spans through the entire
height of the C-lobe, packed against a cleft formed by helices aD/
aE and the beta hairpin bHbI. Difference in sequences at the C-
terminus end of aK between MST1/MST2 and MST3/MST4 (2-
residue deletion) alters the aK packing angle. Interestingly, the
fold in this region in MST3/MST4 is now similar to that adopted
by PAKs whereas the fold adopted by MST1 is comparable to that
adopted by TAO2 (Figure 8).
Surface properties and substrate selectivity
To assess the surface properties, in addition to the three human
MST crystallographic structures available at the PDB, we have
generated two models by homology: MST2 in the active
conformation and MST4 also in the active conformation.
Figure 5. Positioning of aC helix in the structure of three MSTs. The kinase domains were superimposed at the N-lobe. MST1 (magenta),
MST3 (green) and MST4 (blue). PAK6 (yellow wireframe) has been added to the superimposition to highlight the position typically occupied by the aC
helix, in an active kinase.
doi:10.1371/journal.pone.0011905.g005
Human MST Kinases
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four human MSTs in their active conformations is remarkably
similar despite the occurrence of several patches of low residue
conservation (Figure 9). As expected, the surface electrostatic
potential of the crystal structure of MST4 (i.e. inactive
conformation) was significantly different from those in the active
state. This however only highlights the advantages and versatility
of the A-loop exchange autophosphorylation model: (i) that the
sequence to be autophosphorylated does not need to reflect the
kinase’s natural substrate selectivity and (ii) that the domain
swapping, due to the sequence specific packing, will be also highly
specific to the sequence to be autophosphorylated. Additionally,
the lack of variability in surface electrostatic potentials reinforces
the regulatory role of the divergent C-terminal domain of different
MSTs.
Materials and Methods
Cloning, Expression and Purification
The MST4 gene corresponding to residues 1–300 was PCR
amplified from a Mammalian gene collection library clone and
cloned into the expression vector pLIC-SGC1 (SGC) using ligase
independent cloning. The MST4 gene sequence of the constructs
was verified by DNA sequencing. MST4 protein was expressed in
a BL-21(DE3)-R3-pRARE2 cells. The protein was induced by the
addition of IPTG to cells growing in LB ampicillin media. Cells
were harvested following overnight growth and were stored as cell
pellets at 220uC. Approximately 5 grams of cell pellet was
resuspended in 25 ml of 50 mM HEPES pH 7.5, 300mM NaCl,
20 mM imidazole. The resuspended cells were lysed by
sonication. The lysate was cleared of DNA and cell debris by
centrifugation at 20,000 rpm (4uC). Five (5) ml of 50% Ni-NTA
slurry (Qiagen) was applied to a 1.5610 cm gravity column. The
column was equilibrated with 100 ml binding buffer. The lysate
was applied to the column and was subsequently washed with a
minimum of 50 ml of lysis buffer. MST4 was eluted with 25 ml of
lysis buffer containing 100 mM Imidazole. DTT was added to
the eluted MST4 protein to a final concentration of 5 mM. The
N-terminal his6-tag was removed by the addition of approxi-
mately 100 mg of TEV protease and incubated at 4uC overnight.
Kinase phosphorylation was removed by l-phosphatase in the
presence of 50 mM MnCl2. The protein was concentrated using
a 10kDa cutoff ultrafiltration unit and further purified by
fractionation on a size exclusion chromatography HiLoad 16/
60 Superdex 200 column in 50 mM Hepes, pH 7.5, 300 mM
NaCl, 5 mM DTT. The protein was diluted to 50 mM HEPES
pH 7.5, 50 mM NaCl and further purified by fractionation on a
MonoQ column using a 50 mM to 1 M NaCl gradient. The
purity of the protein was confirmed by SDS-PAGE and the
correct molecular weight was observed by ESI Mass spectrosco-
py. The collected protein was concentrated by ultrafiltration
(10kDa cutoff) to 11.2 mg/ml (stored in 50 mM HEPES pH 7.5,
200 mM NaCl), snap frozen in liquid nitrogen and stored
at 280uC.
Analytical Ultracentrifugation
Sedimentation velocity experiments were carried out on a
Beckman Optima XL-I Analytical Ultracentrifuge (Beckman
Instruments, Palo Alto, CA) equipped with an AnTi-50 rotor
and cells with double sector centerpieces. Protein samples were
studied at a concentration of 30 mM in 50 mM HEPES pH 7.5,
100 mM NaCl employing a rotor speed of 45,000 rpm. Radial
absorbance scans were collected using absorbance optics at a
wavelength of 280 nm in continuous scan mode, in 2 minute
intervals. Data were analyzed using the SEDFIT software package
[50] whereby differential sedimentation coefficient distributions,
c(s) distributions, were obtained by direct boundary modeling to
Figure 6. MST4 dimer seen in the asymmetric unit. Chain A is
shown in blue, chain B is shown in orange. A. Overall packing. Cadmium
ions are shown as yellow spheres, ligands are shown as sticks; B.
Molecular interactions seen in the A-loop. Residue Thr178 (to be
phosphorylated) is shown with red labels; C. Surface electrostatics
potential in the dimerization region – the segment involved in the
interaction from the chain B is shown in sticks representation.
doi:10.1371/journal.pone.0011905.g006
Human MST Kinases
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obtained by integration of individual peaks in the calculated c(s)
distributions, after fitting of the frictional ratio, in order to allow
these distributions to be corrected for the effects of diffusion. The
software package SEDNTERP was used in order to convert the
obtained sedimentation coefficient values to the equivalent values
in water at 20uC( s0
20,w,).
Thermal stability shift assay
Thermal melting experiments were carried out using the
Mx3005p real-time PCR machine (Agilent) and employing a
protein concentration of 2 mM and inhibitor concentration of
10 mM. Buffer conditions were 10 mM HEPES, pH 7.5, 500 mM
NaCl and 1:1000 dilution of SyproOrange (Invitrogen, CA). The
assay and data evaluation were carried out as described [51].
Crystallization and Structure determination
Crystallization of MST4 was achieved by sitting drop vapor
diffusion at 4uC. MST4 (stored in 50 mM HEPES pH 7.5,
200 mM NaCl) was pre-incubated with 1mM quinazoline
inhibitor which was added from a 50 mM stock solution in
DMSO at a protein concentration of 5.9 mg/ml. The protein was
crystallized using 12% PEG 3350, 5mM CdCl2, and 0.1M
HEPES, pH 7.0. Viable crystals of the complex were obtained
after microseeding in a 300 nl drop, mixing protein and
precipitant at 2:1 volume ratio. Diffraction data were collected
at Swiss Light Source station X10SA from crystals cryoprotected
with a solution composed of mother liquor and 20% PEG 400 and
flash cooled to 100uK. The data were processed with MOSFLM
[52] and subsequently scaled with SCALA (as implemented in the
CCP4 suite [53]). Structure of MST4 was solved by molecular
Figure 7. Self association and autophosphorylation of MST4 in solution. A: Self association studied by analytical ultracentrifugation. Shown
are sedimentation velocity data. The sedimentation coefficients have been normalized to standard condition. Peaks corresponding to the MST4
monomer and dimer are indicated by ‘‘M and D’’ respectively. B: Autophosphorylation of MST4 studied by ESI-MS. The mass of the unmodified
protein (33.818 Da) has been indicated. In addition to the three detected phosphorylation events the protein also oxidized (+16 mass shifts indicated
by *).
doi:10.1371/journal.pone.0011905.g007
Figure 8. aK and aD conformations for the two subfamilies of MSTs. A. MST1 (magenta) adopts a conformation closer to that seen in TAO2
(red); B. MST3 and 4 (green and blue, respectively) adopts a similar fold to that of PAKs (yellow).
doi:10.1371/journal.pone.0011905.g008
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structure of MST3 (PDB ID: 3CKX) as a model. Initial structure
was obtained by automated model building using the Buccaneer
program [55] supplemented with an improved phase output from
DM (as implemented in the CCP4 suite [53]). Further iterative
cycles of manual rebuilding in COOT [56] and refinement with
REFMAC5 [57] were performed. Appropriate TLS groups
calculated by the TLSMD program [58] were applied to a final
round of TLS refinement. Completed structure was verified for
geometric correctness with MolProbity [59]. Data collection and
refinement statistics are summarized in Table 1.
Homology modeling
Homology modeling was performed using the ICM software
package [60]. The modeling procedure was performed for the full-
length of the MST2 kinase domain, since no crystal structure was
available. We used the structure of the closely related MST1 (PDB
ID: 3COM; sequence identity: 93% for the kinase domain) as the
modeling template. Homology modeling, global minimization to
solve potential clashes derived from the method (e.g. substitutions,
loop modeling/grafting) as well as hydrogen bonding network
optimization were performed using the protocols implemented in
the program ICM [61].
Data deposition
The atomic coordinates and structure factors have been
deposited with the Protein Data Bank, www.rcsb.org (PDB ID:
3GGF [MST4]).
Supporting Information
Datapack S1 Standalone iSee datapack - contains the enhanced
version of this article for use offline. This file can be opened using
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icm_browser.html.
Found at: doi:10.1371/journal.pone.0011905.s001 (ICB)
Text S1 Instructions for installation and use of the required web
plugin (to access the online enhanced version of this article).
Found at: doi:10.1371/journal.pone.0011905.s002 (PDF)
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